Acadian Asset Management
TRIB

Acadian Asset Management’s Trinity Biotech TRIB Stock Holding History

Acadian Asset Management’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,395
Closed -$46K – 2166
2024
Q3 		$46K Sell
1,395
-1,009
-42% -$68.2K ﹤0.01% 1819
2024
Q2 		$149K Sell
2,404
-1,472
-38% -$85.7K ﹤0.01% 1482
2024
Q1 		$237K Sell
3,876
-690
-15% -$48.5K ﹤0.01% 1161
2023
Q4 		$292K Sell
4,566
-258
-5% -$18.5K ﹤0.01% 1153
2023
Q3 		$526K Sell
4,824
-29
-0.6% -$3.56K ﹤0.01% 993
2023
Q2 		$701K Sell
4,853
-97
-2% -$14.1K ﹤0.01% 973
2023
Q1 		$696K Sell
4,950
-58
-1% -$8.97K ﹤0.01% 971
2022
Q4 		$741K Sell
5,008
-60
-1% -$10.9K ﹤0.01% 925
2022
Q3 		$811K Hold
5,068
– – ﹤0.01% 854
2022
Q2 		$931K Sell
5,068
-368
-7% -$67.4K ﹤0.01% 837
2022
Q1 		$862K Sell
5,436
-187
-3% -$32.3K ﹤0.01% 865
2021
Q4 		$1.2M Sell
5,623
-79
-1% -$22.4K ﹤0.01% 788
2021
Q3 		$1.84M Buy
5,702
+114
+2% +$40.1K 0.01% 703
2021
Q2 		$2.46M Buy
5,588
+566
+11% +$282K 0.01% 650
2021
Q1 		$2.83M Buy
5,022
+859
+21% +$620K 0.01% 635
2020
Q4 		$2.38M Buy
4,163
+729
+21% +$362K 0.01% 712
2020
Q3 		$1.04M Buy
3,434
+2,294
+201% +$796K ﹤0.01% 901
2020
Q2 		$373K Buy
+1,140
New +$261K ﹤0.01% 1295
2018
Q4 		– Sell
-39
Closed -$23K – 1836
2018
Q3 		$23K Hold
39
– – ﹤0.01% 1498
2018
Q2 		$29K Buy
+39
New +$28.1K ﹤0.01% 1493
2017
Q2 		– Sell
-319
Closed -$286K – 1590
2017
Q1 		$286K Buy
+319
New +$299K ﹤0.01% 986
2014
Q4 		– Sell
-51
Closed -$140K – 1329
2014
Q3 		$140K Sell
51
-308
-86% -$1M ﹤0.01% 802
2014
Q2 		$1.24M Sell
359
-527
-59% -$1.87M 0.01% 567
2014
Q1 		$3.22M Sell
886
-891
-50% -$3.5M 0.02% 397
2013
Q4 		$6.7M Sell
1,777
-809
-31% -$2.91M 0.04% 302
2013
Q3 		$8.44M Sell
2,586
-462
-15% -$1.35M 0.05% 250
2013
Q2 		$7.7M Buy
+3,048
New +$7.58M 0.05% 240

Other funds holding TRIB

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
WCM
Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
MAWA
Moss Adams Wealth Advisors Seattle, Washington $1.6B AUM 28.24% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
BCM
Becker Capital Management Portland, Oregon $3.72B AUM 31.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Acadian Asset Management's TRIB Position: Q4 2024 in Review

Acadian Asset Management sold out of Trinity Biotech (TRIB) in Q4 2024, closing a stake of 1,395 shares — an estimated $46K sold.

Acadian Asset Management first reported a position in TRIB in Q2 2013 and held it in 27 quarters. The position peaked at $8.44M in Q3 2013. 21 funds tracked by Wall St. Rank hold TRIB as of Q4 2024.

  • Acadian Asset Management reported no remaining Trinity Biotech position as of Q4 2024 after selling out during the quarter.
  • Acadian Asset Management sold 1,395 Trinity Biotech shares in Q4 2024, an estimated $46K.
  • Acadian Asset Management first reported a position in Trinity Biotech in Q2 2013 and held it in 27 quarters.
  • Acadian Asset Management's Trinity Biotech position peaked at $8.44M in Q3 2013.
  • 21 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2024.

Based on Acadian Asset Management's 13F filing for Q4 2024, filed 11 Feb 2025.